CIK: 1509418 - Address: 3000 Kent Ave, Suite A1-100, West Lafayette, IN 47906
23 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

P%ret111-2-215726-515
P%wins00100100100050
S%ret11110-1-2-1-2-13-3
S%wins55644536556453

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

2/26/15 18:30
2/6/15
ECYTEndocyte IncDEHealthDrugPharmaceutical PreparationsEllis P RonINDOP,CEOM.d2735.2135221305D-35-62-11-9616134-21466-18-48
11/7/14 14:17
11/5/14
ECYTEndocyte IncDEHealthDrugPharmaceutical PreparationsEllis P RonINDOP,CEOM.d361.916199226D-18-39-4-3-1218912-7-2-5-21-8-18
3/12/14 19:31
3/10/14
ECYTEndocyte IncDEHealthDrugPharmaceutical PreparationsEllis P RonINDOP,CEOM.d1531.91118064205D27036-11201-12-2-211173-51-42-55
12/4/13 17:24
12/2/13
ECYTEndocyte IncDEHealthDrugPharmaceutical PreparationsEllis P RonINDOP,CEOS.d-3612.004-3-3104D1019-13-253332-4-8217-44-43
12/4/13 17:24
12/4/13
ECYTEndocyte IncDEHealthDrugPharmaceutical PreparationsEllis P RonINDOP,CEOM.d61.91433104D1019-13-253332-4-8217-44-43
11/8/13 16:20
11/6/13
ECYTEndocyte IncDEHealthDrugPharmaceutical PreparationsEllis P RonINDOP,CEOS.d-3612.006-3-3104D928-26-37-26-8-814-3-8-1010-47-54
11/8/13 16:20
11/7/13
ECYTEndocyte IncDEHealthDrugPharmaceutical PreparationsEllis P RonINDOP,CEOM.d61.91633104D928-26-37-26-8-814-3-8-1010-47-54
10/2/13 17:21
10/1/13
ECYTEndocyte IncDEHealthDrugPharmaceutical PreparationsEllis P RonINDOP,CEOS.d-4013.305-3-3104D31356-4-12-7-3-43-2-29-2475-58
10/2/13 17:21
10/2/13
ECYTEndocyte IncDEHealthDrugPharmaceutical PreparationsEllis P RonINDOP,CEOM.d61.91533104D31356-4-12-7-3-43-2-29-2475-58
9/5/13 16:31
9/3/13
ECYTEndocyte IncDEHealthDrugPharmaceutical PreparationsEllis P RonINDOP,CEOS.d-4414.544-3-3104D38565716-9-80-1-5-2-4-25-12-55
9/5/13 16:31
9/4/13
ECYTEndocyte IncDEHealthDrugPharmaceutical PreparationsEllis P RonINDOP,CEOM.d61.91433104D38565716-9-80-1-5-2-4-25-12-55
8/6/13 16:38
8/1/13
ECYTEndocyte IncDEHealthDrugPharmaceutical PreparationsEllis P RonINDOP,CEOS.d-5418.125-3-3104D4012881303744-3-3-8-13-46-35-62
8/6/13 16:38
8/2/13
ECYTEndocyte IncDEHealthDrugPharmaceutical PreparationsEllis P RonINDOP,CEOM.d61.91533104D4012881303744-3-3-8-13-46-35-62
7/17/13 16:32
7/15/13
ECYTEndocyte IncDEHealthDrugPharmaceutical PreparationsEllis P RonINDOP,CEOS.d-5117.015-3-3104D20111812229312-4-1-2-3-40-23-64
7/17/13 16:32
7/16/13
ECYTEndocyte IncDEHealthDrugPharmaceutical PreparationsEllis P RonINDOP,CEOM.d61.91533104D20111812229312-4-1-2-3-40-23-64
5/3/13 16:34
5/1/13
ECYTEndocyte IncDEHealthDrugPharmaceutical PreparationsEllis P RonINDOP,CEOS-713.884-10104D1393453740-2-2-321240-23-48
4/3/13 21:01
4/1/13
ECYTEndocyte IncDEHealthDrugPharmaceutical PreparationsEllis P RonINDOP,CEOS-612.544-10105D641443251343934103746279
3/29/13 19:01
3/27/13
ECYTEndocyte IncDEHealthDrugPharmaceutical PreparationsEllis P RonINDOP,CEOS-1812.003-2-1105D52130213932313217671471577
3/29/13 18:45
12/31/12
ECYTEndocyte IncDEHealthDrugPharmaceutical PreparationsEllis P RonINDOP,CEOS.a-538.753-6-5107D52130213932313217671471577
1/3/13 13:00
12/31/12
ECYTEndocyte IncDEHealthDrugPharmaceutical PreparationsEllis P RonINDOP,CEOS-538.751-6-5108D17216-5233-180-15425613
12/16/11 17:30
12/16/11
ECYTEndocyte IncDEHealthDrugPharmaceutical PreparationsEllis P RonINDOP,CEOM.d391.7942224114D-74-75-67-68-69-69391558141211
8/9/11 18:06
8/5/11
ECYTEndocyte IncDEHealthDrugPharmaceutical PreparationsEllis P RonINDOP,CEOM.d00.190040092D25-20-29-16-28-223116-15-79-20
2/8/11 20:15
2/4/11
ECYTEndocyte IncDEHealthDrugPharmaceutical PreparationsEllis P RonINDOP,CEOP156.0073384D-2-215726-51

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact